Related Experiment Video
Updated: Aug 14, 2026

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Oligoproline effects on polyglutamine conformation and aggregation
Anusri Bhattacharyya1, Ashwani K Thakur, Veronique M Chellgren
1Graduate School of Medicine, University of Tennessee, 1924 Alcoa Highway, Knoxville, TN 37920, USA.
Insights
Adding a P10 sequence to polyglutamine (polyGln) significantly reduces amyloid aggregate formation in neurological disease models. This finding offers new insights into polyGln aggregation and potential therapeutic strategies for diseases like Huntington's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Nine neurological diseases are linked to expanded CAG repeats, causing polyglutamine (polyGln) expansion in proteins.
- The protein context and sequence surrounding polyGln influence its aggregation and disease pathology.
- Huntington's disease (HD) involves polyGln expansion in huntingtin protein, followed by an oligoproline region.
Purpose of the Study:
- To investigate the effect of C-terminal oligoproline sequences on polyglutamine (polyGln) aggregation.
- To determine the optimal length and placement of oligoproline sequences for suppressing polyGln aggregation.
- To explore the mechanism by which oligoproline sequences modulate polyGln aggregation and its implications for neurological diseases.
Main Methods:
- Synthesis of peptides containing polyglutamine (polyGln) sequences with varying C-terminal oligoproline extensions.
- Analysis of amyloid-like aggregate formation using techniques to measure aggregation rate and stability.
- Circular dichroism spectroscopy to assess changes in peptide secondary structure.
- Testing the effect of C-terminal P10 sequence on Abeta fibril formation.
Main Results:
- A C-terminal P10 sequence significantly decreased the rate and stability of polyGln amyloid-like aggregate formation.
- The suppressive effect was maintained with P6 but lost with P3 oligoproline sequences.
- Spacer sequences between polyGln and P10 did not abolish the effect, but N-terminal or tethered P10 sequences were ineffective.
- P10 addition altered the circular dichroism spectra of polyGln peptides, suggesting stabilization of an aggregation-incompetent monomer conformation.
- The P10 sequence's effect on aggregation was transportable, modulating Abeta fibril formation.
Conclusions:
- C-terminal oligoproline sequences, particularly P10, can effectively suppress polyglutamine (polyGln) aggregation.
- The structural context and placement of oligoproline sequences are critical for their inhibitory effect.
- These findings suggest a potential therapeutic strategy for polyGln-repeat neurological diseases by modulating protein aggregation.
Abstract:
There are nine known expanded CAG repeat neurological diseases, including Huntington's disease (HD), each involving the repeat expansion of polyglutamine (polyGln) in a different protein. Similar conditions can be induced in animal models by expression of the polyGln sequence alone or in other protein contexts. Besides the polyGln sequence, the cellular context of the disease protein, and the sequence context of the polyGln within the disease protein, are both likely to contribute to polyGln physical behavior and to pathology. In HD, the N-terminal, exon-1 segment of the protein huntingtin contains the polyGln sequence immediately followed by an oligoproline region. We show here that introduction of a P10 sequence C-terminal to polyGln in synthetic peptides decreases both the rate of formation and the apparent stability of the amyloid-like aggregates associated with this family of diseases. The sequence can be trimmed to P6 without altering the suppression, but a P3 sequence is ineffective. Spacers up to at least three amino acid residues in length can be inserted between polyGln and P10 without altering this effect. There is no suppression, however, when the P10 sequence is either placed on the N-terminal side of polyGln or attached to polyGln via a side-chain tether. The nucleation mechanism of a Q40 sequence is unchanged upon addition of a P10 C-terminal extension, yielding a critical nucleus of one. The effects of oligoPro length and structural context on polyGln aggregation are correlated strongly with alterations in the circular dichroism spectra of the monomeric peptides. For example, the P10 sequence eliminates the small amount of alpha helical content otherwise exhibited by the Q40 sequence. The P10 sequence may suppress aggregation by stabilizing an aggregation-incompetent conformation of the monomer. The effect is transportable: a P10 sequence fixed to the C terminus of the sequence Abeta similarly modulates amyloid fibril formation.
Related Concept Videos
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein Folding Quality Check in the RER
Protein Organization
Protein Organization
The primary structure of a protein is its amino acid sequence.
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

